Study of the Mechanisms of Asthma

PHASE1CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Asthma
Interventions
DRUG

Pulmicort

inhaled powder of inhaled corticosteroid, 1 puff (180mcg) twice a day for 8-10 weeks

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT00595153 - Study of the Mechanisms of Asthma | Biotech Hunter | Biotech Hunter